Diacylglycerol Signaling

21 PKC and Resistance to Chemotherapeutic Agents
Ding, L., Wang, H., Lang, W., & Xiao, L. (2002). Protein kinase C-epsilon promotes survival of
lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase
pathway. The Journal of Biological Chemistry, 277, 35305–35313.
Dolci, E. D., Abramson, R., Xuan, Y., Siegfried, J., Yuenger, K. A., Yassa, D. S., et al. (1993).
Anomalous expression of P-glycoprotein in highly drug-resistant human KB cells. International
Journal of Cancer, 54, 302–308.
Dong, Z. Y., Ward, N. E., Fan, D., Gupta, K. P., & O’Brian, C. A. (1991). In vitro model for
intrinsic drug resistance: Effects of protein kinase C activators on the chemosensitivity of
cultured human colon cancer cells. Molecular Pharmacology, 39, 563–569.
Eastman, A. (1990). Activation of programmed cell death by anticancer agents: Cisplatin as a
model system. Cancer Cells, 2, 275–280.
Efferth, T., & Volm, M. (1992). Expression of protein kinase C in human renal cell carcinoma cells
with inherent resistance to doxorubicin. Anticancer Research, 12, 2209–2211.
Fan, D., Fidler, I. J., Ward, N. E., Seid, C., Earnest, L. E., Housey, G. M., et al. (1992). Stable
expression of a cDNA encoding rat brain protein kinase C-beta I confers a multidrug-resistant
phenotype on rat fibroblasts. Anticancer Research, 12, 661–667.
Ferguson, P. J., & Cheng, Y. C. (1987). Transient protection of cultured human cells against
antitumor agents by 12-O-tetradecanoylphorbol-13-acetate. Cancer Research, 47, 433–441.
Filomenko, R., Poirson-Bichat, F., Billerey, C., Belon, J. P., Garrido, C., Solary, E., et al. (2002).
Atypical protein kinase C zeta as a target for chemosensitization of tumor cells. Cancer
Research, 62, 1815–1821.
Fine, R. L., Patel, J., & Chabner, B. A. (1988). Phorbol esters induce multidrug resistance in
human breast cancer cells. Proceedings of the National Academy of Sciences of the United
States of America, 85, 582–586.
Fisher, D. E. (1994). Apoptosis in cancer therapy: Crossing the threshold. Cell, 78, 539–542.
Flescher, E., & Rotem, R. (2002). Protein kinase C epsilon mediates the induction of P-glycoprotein
in LNCaP prostate carcinoma cells. Cellular Signalling, 14, 37–43.
Ganeshaguru, K., Wickremasinghe, R. G., Jones, D. T., Gordon, M., Hart, S. M., Virchis, A. E.,
et al. (2002). Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic
leukemia cells in vitro. Haematologica, 87, 167–176.
Gately, D. P., & Howell, S. B. (1993). Cellular accumulation of the anticancer agent cisplatin:
A review. British Journal of Cancer, 67, 1171–1176.
Geiger, T., Muller, M., Dean, N. M., & Fabbro, D. (1998). Antitumor activity of a PKC-alpha
antisense oligonucleotide in combination with standard chemotherapeutic agents against various
human tumors transplanted into nude mice. Anti-Cancer Drug Design, 13, 35–45.
Gekeler, V., Boer, R., Ise, W., Sanders, K. H., Schachtele, C., & Beck, J. (1995). The specific bisindolylmaleimide
PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple
drug resistance. Biochemical and Biophysical Research Communications, 206, 119–126.
Germann, U. A., Chambers, T. C., Ambudkar, S. V., Licht, T., Cardarelli, C. O., Pastan, I., et al.
(1996). Characterization of phosphorylation-defective mutants of human P-glycoprotein
expressed in mammalian cells. The Journal of Biological Chemistry, 271, 1708–1716.
Gill, P. K., Gescher, A., & Gant, T. W. (2001). Regulation of MDR1 promoter activity in human
breast carcinoma cells by protein kinase C isozymes alpha and theta. European Journal of
Biochemistry, 268, 4151–4157.
Gollapudi, S., Soni, V., Thadepalli, H., & Gupta, S. (1995). Role of protein kinase beta isozyme
in multidrug resistance in murine leukemia P388/ADR cells. Journal of Chemotherapy, 7,
157–159.
Goodfellow, H. R., Sardini, A., Ruetz, S., Callaghan, R., Gros, P., McNaughton, P. A., et al.
(1996). Protein kinase C-mediated phosphorylation does not regulate drug transport by the
human multidrug resistance P-glycoprotein. The Journal of Biological Chemistry, 271,
13668–13674.
Hall, M. D., Okabe, M., Shen, D. W., Liang, X. J., & Gottesman, M. M. (2008). The role of
cellular accumulation in determining sensitivity to platinum-based chemotherapy. Annual
Review of Pharmacology and Toxicology, 48, 495–535.
425